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may be related to a more restrictive regional approach and does not appear
to affect clinical outcomes including 30 day-mortality and recurrent MI.
Conclusion: Marked differences are present among these 3 scoring sys-
tems. Factors contributing to these differences should be clarified before
they are widely applied 10 patient care.
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Prospective Application of RAND Expert Panel
Ratings, ACC/AHA Guidelines, and the University of
Maryland Revascularizatlon Appropriateness Score
(RAS): Only RAS Predicts Clinical Outcome
Understanding the reasons for variations in physician resource utilization in
coronary angioplasty (PlCA) and coronary surgery (CABG) is essential to ef-
ficiently organizing, managing, and paying for these procedures. lo evaluate
the extent of variations in physician resource utilization for CABGs and PlCAs
and the reasons for these variations, the resource-based relative value scale
(RBRVS), an index of relative weights for physician work and practice costs,
is used to evaluate physician practice patterns. Given their extensive clinical
review, RBRVS weights represent new, unique, comprehensive measures of
physician resource utilization where 1 unit value is equivalent to an interme-
diate office visit for an established patient. Our investigation uses 3 years of
clinical and financial data on 392 randomized patients with multivessel coro-
nary artery disease (EASl data). receiving the initial therapy of either CABG
or PlCA. RBRVS weights are assigned to each procedure code (CPl) and
the distribution of RBRVS units and their allocation among different types
of services are analyzed. Results show significant differences in physician
resources for both CABGs and PlCAs. Among CABG patients, nearly a nine-
fold variation in physician resource units is evident (108 ± 46) and, for PlCA,
a 29-fold variation exists (66 ± 54). At three years, the average physician re-
source utilization for CABG is 64% greater than PlCA. Significant differences
are also evident in surgical, laboratory, imaging, and consult resources even
after accounting for casemix. The findings demonstrate that the RBRVS is a
viable and useful analytical tool for managerial and clinical personnel.
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Several scoring systems exist for evaluating the appropriateness of PlCA
and CABG. However, they have not been prospectively correlated with out-
come. We prospectively studied 61 pts referred to the catheterization labo-
ratory who were treated with PlCA (33). CABG (15) or medical therapy (13).
Forty-five were male; the mean age was 60.2 ± 12.8 years (range 32-87). Dur-
ing a mean followup of 9.3 ± 3.8 months {range 3-16.1),66 events occurred
in 35 patients including angina (25), MI (3), death (6), cardiac readmission
{171. PlCA (4), CABG (7), CHF (4).
For all patients, revascularization appropriateness was ranked by the RAS,
ACC/AHA. and RAND Scoring systems. Application of RAS yielded revascu-
larization appropriateness ratings of Necessary (N), Appropriate (AI, or Inap-
propriate (I). Of 11 patients ranked N who did not receive revascularization, 10
had adverse events, compared with 17 of 35 who received revascularization
(p = 0.02). Of 5 pts ranked I for revascularization who received either PlCA
or CABG, 3 had adverse events. In total, 13 of 16 pts who received treatment
that was discordant with a N or I RAS rating had adverse events, compared
with 20 of 45 who received concordant treatment. (p = 0.021. These dis-
cordant treatments included unnecessary PlCA (5). failure to perform CABG
(1), PlCA (3), or either (7). Statistical significance persisted when only "hard"
events (excluding angina) were considered (p = 0.03). Concordance of treat-
ment with RAND and ACC/AHA revascularization appropriateness scores for
PlCA and CABG were not predictive of adverse events in this population.
Conclusion: Revascularization appropriateness scoring systems differ in
their ability to predict outcomes. Of the 3 approaches studied, only treatment











Although different scoring systems have been used to evaluate the appro-
priateness of PlCA and CABG, they have not been directly compared. For
100 patients referred to the catheterization laboratory, we prospectively com-
pared the RAND Expert Panel Ratings, ACC/AHA Guidelines and the Univer-
sity of Maryland Revascularization Appropriateness Score (RAS). The patient
population included stable angina (25%), unstable angina (33%). post-MI
(27%), acute MI (7%). asymptomatic with + En or pre-op (7%). and sud-
den death (1 %). Pts were treated with PlCA(62%). CABG (19%), or medical
therapy(19%).
There were significant differences among the 3 systems for PlCA and
CABG appropriateness. ACC/AHA and RAS were more definitive in assigning
revascularization scores than RAND which yielded uncertain ratings in 17%
for CABG and 38% for PlCA. ACC/AHA differed markedly in the Inappropri-
ate/Class III rating for both CABG and PlCA.
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After acute myocardial infarction (AMI). the American College of Cardiology
and the American Heart Association recommend angiography in patients "if
the prognosis is judged to be poor ... and ... outcome can be improved by
urgent bypass surgery or coronary angioplasty (PlCA)." In 4823 consecutive
survivors of AMI, we examined the relationship between both angiography
(n = 2274) and revascularization (n = 692 for PlCA, n = 469 for bypass
surgery) and 7 clinical variables that predict mortality (age, recurrent angina,
ejection fraction, heart failure, use of thrombolytics, prior infarction, cardio-
genic shock).
Multivariate logistic regression revealed that except for recurrent angina,
most factors predicting higher mortality were associated with a lower use of
angiography (OR(95%CI) = 2.75 (2.39-3.17) for recurrent angina, 0.47 (0.43-
0.51) for older age, 0.85 (0.74-0.97) for prior infarction, 0.50 (0.43--0.59) for no
thrombolytic treatment, and 0.63 (0.5S--O.73) for heart failure during hospital-
ization). A similar relationship was observed among patients who underwent
PlCA (OR(95%CI) = 1.94 (1.53-2.47) for recurrent angina, 0.51 (0.40-0.65)
for low ejection fraction, 0.72 (0.57--0.93) for no thrombolytic therapy and
0.74 (0.56--0.98) for history of prior infarction). In contrast, patients with un-
favorable prognostic profiles were more likely to undergo coronary bypass
surgery (OR(95%CI) = 1.66 (1.34-2.06) for recurrent angina, 1.28 (1.11-1.47)
for older age, 2.24 (1.78-2.82) for heart failure, 1.46 (1.18-1.80) for prior in-
farction and 1.28 for no thrombolytic therapy).
Angiography and PlCA are performed more often in patients who are at
relatively low risk for subsequent mortality. Since there is currently no evi-
dence of a survival advantage from PlCA, the risks of this procedure could
be avoided in some patients by initially treating them conservatively and sub-
sequently performing PlCA in only those patients whose symptoms are not
controlled with medications alone.
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